Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Oral Drug Delivery Systems: Delayed-Release Systems01:11

Oral Drug Delivery Systems: Delayed-Release Systems

Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optical-Controlled One-Pot RPA-CRISPR Assay for Environmental DNA Detection of a Critically Endangered Species.

ACS sensors·2026
Same author

Prevalence and cardiovascular phenotypes of dextrocardia and situs inversus among 277,396 adults: longitudinal evidence of amplified age-related blood pressure progression.

Orphanet journal of rare diseases·2026
Same author

Clinical Study of Clay Pot Combined With Thunder Fire Moxibustion in the Treatment of Chronic Refractory Wounds in Department of Orthopedics.

Medical science monitor : international medical journal of experimental and clinical research·2026
Same author

Editorial Expression of Concern: Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas.

Journal of cancer research and clinical oncology·2026
Same author

Association of middle cerebral artery atherosclerotic plaque with vessel tortuosity and white matter hyperintensity.

Neuroradiology·2026
Same author

ACE2 ameliorates DOX-induced cardiotoxicity by suppressing excessive autophagy via the AMPK/mTOR signaling pathway.

Biochemical pharmacology·2026

Related Experiment Video

Updated: Jul 7, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

Novel biodegradable blend matrices for controlled drug release.

Mei Lin1, Sheng Meng, Wei Zhong

  • 1Key Laboratory of Molecular Engineering of Polymers of Ministry of Education, Department of Macromolecular Science, Fudan University, Shanghai 200433, China.

Journal of Pharmaceutical Sciences
|February 14, 2008
PubMed
Summary

Adding phosphorylcholine-functionalized poly-epsilon-caprolactone (PC-PCL) to poly-epsilon-caprolactone (PCL) enhances ibuprofen release. This biodegradable polymer blend offers tunable drug delivery based on PC-PCL content and PCL molecular weight.

More Related Videos

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

Bacterial Cellulose Spheres that Encapsulate Solid Materials
04:42

Bacterial Cellulose Spheres that Encapsulate Solid Materials

Published on: February 26, 2021

Related Experiment Videos

Last Updated: Jul 7, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

Bacterial Cellulose Spheres that Encapsulate Solid Materials
04:42

Bacterial Cellulose Spheres that Encapsulate Solid Materials

Published on: February 26, 2021

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Drug Delivery Systems

Background:

  • Poly-epsilon-caprolactone (PCL) is a biocompatible and biodegradable polymer.
  • Phosphorylcholine-functionalized PCL (PC-PCL) is a novel polymer with enhanced properties.
  • Controlled drug release systems require careful material selection and formulation.

Purpose of the Study:

  • To investigate the controlled release of Ibuprofen (IB) from PCL using direct blending with PC-PCL.
  • To evaluate the impact of PC-PCL content, drug loading, and PCL molecular weight on IB release kinetics.
  • To elucidate the release mechanisms governed by blend hydrophilicity and degradation.

Main Methods:

  • Direct blending of PC-PCL with PCL to form drug-loaded matrices.
  • Modulation of blend composition (PC-PCL content) and PCL molecular weight.
  • Controlled release studies of Ibuprofen (IB) under varying conditions.
  • Analysis of release profiles using power law kinetics and degradation/erosion studies.

Main Results:

  • Increased PC-PCL content in the blend significantly enhanced IB release rates.
  • Higher molecular weight PCL in the blend resulted in decreased IB release rates.
  • Drug loading influenced the overall release properties of the PC-PCL/PCL matrices.
  • The release mechanism was predominantly governed by diffusion kinetics, influenced by blend hydrophilicity and biodegradability.

Conclusions:

  • PC-PCL blending offers a viable strategy to modulate Ibuprofen release from PCL matrices.
  • The hydrophilicity and biodegradability of the blend are key factors controlling drug release.
  • This study demonstrates tunable drug delivery potential for PC-PCL/PCL blends, with diffusion as the primary release mechanism.